Pain Self-Efficacy Questionnaire (PSEQ)

Abstract

The Pain Self-Efficacy Questionnaire (PSEQ) is an internationally recognized, 10-item patient-reported outcome measure developed by Professor Michael K. Nicholas. Designed to assess the confidence individuals with chronic and persisting pain possess in executing a diverse spectrum of daily activities, occupational demands, social interactions, and psychological coping mechanisms despite their ongoing pain experience, the instrument operationalizes the core tenets of Albert Bandura's Social Cognitive Theory. The PSEQ covers functional domains ranging from domestic responsibilities and recreational pursuits to vocational tasks and pain control without medication reliance. Respondents rate each item on a 7-point numerical rating scale ranging from 0 (“Not at all confident”) to 6 (“Completely confident”), yielding a total cumulative score between 0 and 60, with higher scores reflecting stronger pain self-efficacy beliefs. Extensive psychometric investigations have established that the PSEQ possesses robust internal consistency (α ≥ .92), high test-retest reliability across multi-month intervals (r = .73 to .80), and exemplary construct, convergent, and predictive validity. Factor analytic evaluations predominantly substantiate a robust, parsimonious unifactorial structure across varied musculoskeletal, neuropathic, and systemic chronic pain populations. Clinically, PSEQ scores serve as vital predictors of functional recovery, return-to-work success, medication tapering, and resilience against pain-related disability, establishing the instrument as an indispensable cornerstone of cognitive-behavioral and interdisciplinary pain rehabilitation.

Keywords

Pain Self-Efficacy Questionnaire, PSEQ, chronic pain, self-efficacy, psychometrics, functional disability, Michael K. Nicholas, cognitive-behavioral therapy, pain rehabilitation, patient-reported outcome measures, musculoskeletal pain, construct validity.

Authors

The Pain Self-Efficacy Questionnaire was developed by Michael K. Nicholas, PhD. Professor Nicholas is an internationally renowned clinical psychologist, researcher, and educator in the field of cognitive-behavioral pain management:

• Primary Affiliation: Pain Management Research Institute (PMRI), Northern Clinical School, The University of Sydney and Royal North Shore Hospital, Sydney, New South Wales, Australia.
• Academic Profile: Professor of Pain Medicine and Director of Pain Education at the University of Sydney Faculty of Medicine and Health.
• Contact / Institutional Address: Pain Management Research Institute, Level 13, Kolling Building, Royal North Shore Hospital, St Leonards NSW 2065, Australia.

Purpose

The primary clinical and psychometric objective of the Pain Self-Efficacy Questionnaire (PSEQ) is to quantify an individual's specific cognitive conviction that they can perform functional activities, sustain interpersonal roles, and maintain psychological stability despite the presence of ongoing physical pain. In chronic pain conditions—such as axial low back pain, complex regional pain syndrome, fibromyalgia, osteoarthritis, and neuropathic disorders—symptom intensity alone demonstrates surprisingly modest associations with objective functional impairment and vocational incapacity. Instead, cognitive appraisals and behavioral expectations mediate the relationship between nociceptive input and overt behavioral disability. The PSEQ was intentionally engineered to measure these mediating self-efficacy expectations directly.

From an applied clinical perspective, the PSEQ provides clinicians and multidisciplinary care teams with vital baseline metrics and tracking parameters across interventions. Specifically, the instrument fulfills three principal purposes:

• Risk Stratification and Prognostication: At baseline assessment, low PSEQ scores (e.g., below 20 or 30 points) identify patients at heightened risk for protracted functional disability, prolonged sickness absence, severe affective distress, and treatment non-adherence. Conversely, higher baseline scores forecast favorable responses to physical reactivation and active self-management.
• Treatment Target Identification: The questionnaire isolates specific functional domains wherein patients hold profound self-efficacy deficits (such as coping without analgesic medication or sustaining occupational tasks). Interdisciplinary teams can consequently tailor cognitive-behavioral therapy (CBT), graded exposure therapy, and functional restoration programs to target these precise self-efficacy deficits.
• Outcome Monitoring and Program Evaluation: As an outcome measure, the PSEQ is exquisitely sensitive to therapeutic change. Measuring shifts in pain self-efficacy across cognitive-behavioral, pharmacological, and physical rehabilitation programs enables clinicians to assess whether the patient has shifted from passive helplessness to active, confident self-regulation.

In empirical research, the PSEQ operates as an essential explanatory variable in structural equation models and clinical trials examining the efficacy of multidisciplinary pain programs, pharmacotherapies, spinal cord stimulation, and targeted psychosocial interventions. It enables researchers to untangle the distinct mechanisms of therapeutic change, demonstrating whether interventions successfully decouple pain severity from behavioral avoidance.

Psychological Construct

The psychological construct assessed by the PSEQ is pain-related self-efficacy, which represents an application of Albert Bandura's general self-efficacy construct to the context of chronic pain. Bandura defined self-efficacy as an individual's subjective belief in their capabilities to organize and execute the courses of action required to produce given attainments. Crucially, self-efficacy is not a measure of physical capacity, raw physiological strength, or skills possessed; rather, it is a generative cognitive judgment concerning what one can accomplish across demanding or threatening circumstances given their current state.

In pain psychology, pain self-efficacy is conceptually distinguished from several related cognitive constructs:

• Outcome Expectations: While an outcome expectation is the belief that a specific action will lead to a particular result (e.g., “Gradually walking every day will eventually improve cardiovascular health”), an efficacy expectation is the internal conviction that one is personally capable of performing that action in the presence of noxious sensations (e.g., “I am confident I can walk around the neighborhood today despite my back pain”).
• Pain Catastrophizing: As operationalized by instruments such as the Pain Catastrophizing Scale, catastrophizing represents an exaggerated negative mental set brought to bear during actual or anticipated pain experiences (characterized by rumination, magnification, and helplessness). While catastrophizing reflects an acute, threat-focused appraisal of pain sensations, pain self-efficacy reflects an overarching confidence in functional resilience and behavioral agency despite those sensations. They share an inverse empirical relationship but remain divergent constructs.
• Pain Acceptance: As measured by instruments like the Chronic Pain Acceptance Questionnaire (CPAQ), acceptance involves the willingness to experience pain without attempting to avoid, control, or reduce it, while pursuing valued life goals. Pain self-efficacy focuses explicitly on personal mastery and confidence in carrying out concrete activities and coping responses regardless of pain.

The PSEQ evaluates this self-efficacy construct across multiple behavioral domains embedded within its 10 items:

• Affective and Hedonic Capacity (Items 1 and 6): Appraising one's capacity to derive pleasure, engagement, and emotional fulfillment from hobbies and life activities despite ongoing pain, countering the depressive anhedonia frequently precipitated by chronic symptoms.
• Domestic and Everyday Instrumental Functioning (Item 2): Assessing the conviction that basic, domestic tasks (e.g., household chores, tidying, cleaning) can be successfully executed despite discomfort.
• Social and Interpersonal Engagement (Item 3): Capturing the perceived ability to sustain relational commitments, community ties, and interpersonal connections at pre-morbid frequencies without yielding to social withdrawal.
• Coping and Psychological Resilience (Items 4 and 7): Measuring the belief in one's ability to handle pain across varied settings and situations, specifically including coping without reflexive reliance on analgesic medications.
• Vocational and Productive Capacity (Item 5): Evaluating perceived capacity to engage in work-related activities, broadly conceptualized to include paid employment, unpaid labor, and structured productive tasks.
• Existential and Broad Life Goals (Items 8 and 9): Assessing high-level self-efficacy concerning the attainment of core life goals and the preservation of an authentic, subjectively defined “normal lifestyle.”
• Behavioral Reactivation and Physical Progression (Item 10): Measuring forward-looking confidence in achieving graded physical reactivation and progressive increases in physical demand over time.

Theoretical Framework

The Pain Self-Efficacy Questionnaire is grounded in the convergence of three foundational paradigms in behavioral medicine: Bandura's Social Cognitive Theory, the Fear-Avoidance Model of Chronic Pain, and the broader Biopsychosocial Model.

1. Social Cognitive Theory (Bandura)

According to Bandura (1977, 1997), human functioning is sustained through triadic reciprocal causation, in which cognitive, biological, and affective events, behavioral patterns, and environmental influences operate as interacting determinants that influence each other bidirectionally. Efficacy beliefs constitute the foundational pivot of human agency. Bandura posited four principal sources of self-efficacy information:

• Mastery Experiences (Performance Accomplishments): Direct, successful execution of an activity provides the most authentic evidence of capability. In pain rehabilitation, successful exposure to physical movements without catastrophic reinjury builds mastery beliefs.
• Vicarious Experiences: Observing comparable peers successfully navigate pain and sustain productive activities strengthens the observer's belief that they too can overcome functional obstacles.
• Verbal and Social Persuasion: Encouragement, cognitive restructuring, and psychoeducation from clinicians and support systems help dismantle somatic anxiety and foster behavioral willingness.
• Physiological and Affective States: Somatosensory feedback, autonomic arousal, and subjective pain sensations are often misinterpreted by chronic pain patients as indicators of impending physical harm. Enhancing self-efficacy requires altering how these somatic states are cognitively interpreted.

2. The Fear-Avoidance Model of Chronic Pain

Formulated comprehensively by Vlaeyen and Linton (2000), the Fear-Avoidance Model delineates two divergent trajectories following a painful musculoskeletal injury. When pain is appraised as non-threatening, individuals engage in confrontational behaviors, maintain baseline activity, and progress toward recovery. However, when pain is catastrophically appraised, it triggers pain-related fear (kinesiophobia), leading directly to safety-seeking behaviors, hypervigilance, and pervasive avoidance.

Within this theoretical architecture, pain self-efficacy functions as a critical protective buffer and resilience factor. High pain self-efficacy interrupts the fear-avoidance spiral. Even when individuals experience elevated pain sensations, a strong sense of self-efficacy prevents the translation of pain into catastrophic fear and subsequent behavioral avoidance. Patients with robust self-efficacy recognize that pain does not equate to structural harm, remaining willing to engage in graded activity and maintaining functional independence.

3. The Biopsychosocial Model

The biopsychosocial framework (Engel, 1977; Turk & Flor, 1999) emphasizes that chronic pain is a complex, dynamic interplay between neurophysiological processing, psychological appraisal, and socio-environmental context. The PSEQ operationalizes this paradigm by capturing how psychological agency modulates the lived manifestation of physical pathology. It demonstrates that disability is not an inevitable, linear mechanical outcome of anatomical tissue damage, but rather a malleable psychological state governed by the patient's confidence in navigating their physical and social environments.

Validity

The construct, convergent, discriminant, and predictive validity of the PSEQ have been scrutinized across dozens of international empirical studies, demonstrating exceptional psychometric integrity across diverse diagnostic cohorts, healthcare settings, and cultural populations.

Construct and Convergent Validity

In his foundational validation study, Nicholas (2007) administered the PSEQ to a large cohort of chronic pain patients (N = 590) presenting to an interdisciplinary tertiary pain clinic. The PSEQ exhibited profound, statistically significant negative correlations with validated indices of pain-related functional disability, including the Roland-Morris Disability Questionnaire (RMDQ) (r = -.69 to -.71) and the Oswestry Disability Index (ODI). Strong inverse correlations were similarly established with psychological distress markers, such as the Beck Depression Inventory (BDI; r = -.60), the Pain Catastrophizing Scale (PCS) (r = -.58 to -.64), and the Tampa Scale for Kinesiophobia (TSK; r = -.53).

Conversely, the PSEQ demonstrated positive correlations with proactive cognitive coping strategies (measured via the Coping Strategies Questionnaire), active physical functioning scales of the SF-36, and measures of pain acceptance. In a landmark cross-cultural validation by Vong et al. (2009) involving 120 Chinese individuals with chronic musculoskeletal pain (mean duration 31 months across lower back, neck, shoulder, and knee sites), the Chinese PSEQ exhibited substantial convergent validity, correlating robustly with physical performance measures, self-rated functional capacity, and health-related quality of life.

Discriminant Validity

The PSEQ displays excellent discriminant validity by demonstrating markedly weaker correlations with raw pain intensity (typically ranging between r = -.25 and -.35 with Visual Analogue Scale [VAS] or Numerical Rating Scale [NRS] pain ratings) than with functional, psychological, and disability measures. This divergence confirms that the instrument measures personal confidence and behavioral agency rather than merely mirroring instantaneous nociceptive sensations. Individuals with identical high-intensity pain levels can and do display widely divergent PSEQ scores.

Predictive and Criterion Validity

Prospective longitudinal investigations have confirmed the PSEQ's predictive utility across rehabilitation programs:

• Return-to-Work Outcomes: Adams and Williams (2003), alongside Cohen et al. (2000), established that chronic pain patients achieving post-treatment PSEQ scores of approximately 40 or higher were significantly more likely to resume gainful employment and maintain occupational engagement at 12-month follow-up compared to those with lower scores.
• Sustainability of Gains: Research by Couglan et al. (1995) and subsequent cohorts demonstrated that patients completing intensive cognitive-behavioral pain management programs with PSEQ scores below 30 were substantially more vulnerable to relapse, increased medical utilization, and rapid erosion of functional gains.
• Medication Reduction: Nicholas et al. demonstrated that increases in PSEQ scores over the course of multidisciplinary rehabilitation longitudinally predict successful tapering and cessation of prescription opioid analgesics and sedative medications, independent of shifts in reported pain severity.

Reliability

The reliability of the PSEQ has been rigorously substantiated across numerous clinical trials and psychometric investigations, consistently satisfying and exceeding the strict criteria outlined by the COSMIN (Consensus-based Standards for the selection of health Measurement Instruments) initiative.

Internal Consistency

Across validation studies spanning two decades, the PSEQ has consistently yielded excellent internal consistency values:

• Nicholas (2007): In the primary development and validation cohort of 590 chronic pain patients, Cronbach's alpha was calculated at α = .92.
• Vong et al. (2009): In their cross-cultural validation of the Chinese PSEQ, the internal consistency remained exceptionally high at α = .93, with corrected item-total correlations ranging from .62 to .81 across all 10 items.
• Subsequent International Validations: Adaptations into European, Asian, and South American languages—including French (α = .90), Spanish (α = .91), German (α = .92), Persian (α = .93), and Brazilian Portuguese (α = .90)—have uniformly reported Cronbach's alpha and McDonald's omega values exceeding .90, demonstrating that the 10 items operate as a remarkably cohesive, unified psychological measurement scale.

Test-Retest Reliability and Measurement Error

The temporal stability of the PSEQ has been verified across various retest intervals among clinically stable chronic pain populations:

• Long-Term Stability: Nicholas (2007) established strong test-retest reliability across a 3-month observational baseline interval prior to intervention (r = .73 to .80), demonstrating that self-efficacy beliefs remain stable in the absence of active cognitive or behavioral interventions.
• Short-Term Stability: In studies employing shorter retest windows of 7 to 14 days, intraclass correlation coefficients (ICC, two-way mixed effects model) have consistently ranged between .85 and .93, confirming that the scale is not unduly subject to day-to-day fluctuations in transient pain intensity.
• Standard Error of Measurement (SEM) and Minimal Detectable Change (MDC): Psychometric evaluations establish the Standard Error of Measurement (SEM) between 2.5 and 3.5 points on the 0–60 scale. The Minimal Detectable Change at the 95% confidence interval (MDC₉₅) is typically calculated between 5.5 and 8.0 points, indicating that a score change of ≥ 8 points represents true individual clinical change beyond measurement error.

Factor Analysis

The internal dimensionality of the PSEQ has been extensively evaluated through both Exploratory Factor Analysis (EFA) and Confirmatory Factor Analysis (CFA), with the substantial majority of literature supporting a parsimonious, robust unifactorial (single-factor) model.

Exploratory Factor Analysis (EFA)

In Nicholas's original 2007 investigation, principal components analysis with varimax rotation was executed on the 10 items. The analysis unequivocally demonstrated a single primary factor accounting for more than 50% of the total variance (eigenvalue = 5.76). Item factor loadings on this solitary construct were exceptionally high across the board, ranging from .60 to .88:

• Item 1 (Enjoy things): .76
• Item 2 (Household chores): .73
• Item 3 (Socialise with friends/family): .72
• Item 4 (Cope in most situations): .77
• Item 5 (Do some form of work): .78
• Item 6 (Hobbies or leisure): .80
• Item 7 (Cope without medication): .60
• Item 8 (Accomplish life goals): .84
• Item 9 (Live normal lifestyle): .88
• Item 10 (Gradually become more active): .73

Item 7 (“I can cope with my pain without medication”) consistently exhibits the lowest relative loading (typically .55 to .65 across various cultural datasets) while still easily surpassing standard retention thresholds (.40). This modest attenuation occurs because medication reliance is subject to external pharmacological management, prescription policies, and biological dependence, introducing unique variance distinct from purely physical and social activities.

Confirmatory Factor Analysis (CFA)

Confirmatory factor analytic investigations have evaluated the fit of this single-factor solution across large, heterogeneous clinical samples. Vong et al. (2009) subjected the Chinese translation to rigorous CFA using structural equation modeling. The unifactorial model yielded adequate to excellent fit indices:

• Comparative Fit Index (CFI): .94 to .97 across studies, surpassing the conventional .90 threshold for acceptable model fit.
• Tucker-Lewis Index (TLI): .92 to .96.
• Root Mean Square Error of Approximation (RMSEA): .06 to .08, indicating an acceptable to good approximation of the population covariance matrix.
• Standardized Root Mean Square Residual (SRMR): .04 to .05, comfortably below the conservative .08 criterion.

While occasional alternative models have been explored in the literature—such as a two-factor model dissociating active functional performance from internal psychological coping—the overwhelming consensus across international psychometric consensus reports affirms that the unifactorial structure provides the most parsimonious, statistically robust, and clinically meaningful representation of pain self-efficacy.

Instrument / Measurement Tool

• Test Type: Patient-Reported Outcome Measure (PROM); psychological self-report questionnaire.
• Administration Format: Self-administered; accessible via pen-and-paper, digital web portals, mobile clinical applications, or structured clinical interview.
• Target Population: Adults and adolescents experiencing persistent, chronic, or subacute pain presentations (e.g., musculoskeletal back/neck pain, widespread fibromyalgia, inflammatory arthritis, neuropathic pain, pelvic pain, post-surgical pain syndromes).
• Estimated Completion Time: 2 to 3 minutes.
• Number of Items: 10 items.
• Item Content: Concrete behavioral activities including domestic chores, social relationships, occupational functioning, recreation/hobbies, goal setting, general coping, coping without medications, and progressive physical reactivation.
• Response Scale: 7-point numerical rating scale anchored from 0 (“Not at all confident”) to 6 (“Completely confident”).
• Scoring Procedure:
  • Computed by simple direct addition of the numerical ratings across all 10 items.
  • Score Range: 0 to 60 points.
  • Reverse Scoring: None. All items are positively keyed toward greater confidence.
  • Missing Data Handling: If more than two items (i.e., > 20%) are missing, the questionnaire should be deemed invalid and not scored. If only one or two items are omitted, the mean of the completed items may be imputed to substitute the missing values prior to summing.
• Clinical Interpretation Guidelines:
  • < 20 (Severe Self-Efficacy Deficit): Indicates profound functional helplessness and deep pessimism regarding one's physical capability. Highly correlated with severe catastrophizing, elevated fear-avoidance, profound disability, and high risk of long-term vocational failure.
  • 20 – 30 (Moderate Deficit): Reflects significant perceived limitation and fear of symptom exacerbation through activity. Suggests vulnerability to treatment non-compliance and less sustainable functional gains unless targeted cognitive-behavioral reconditioning is integrated.
  • 31 – 40 (Moderate-to-High Self-Efficacy): Represents meaningful behavioral confidence across everyday settings. Patients in this range display realistic willingness to participate in graded reconditioning and functional restoration.
  • > 40 (Robust / Protective Self-Efficacy): Strongly associated with maintenance of functional gains, active coping, low illness-related disability, and successful return to work (Adams & Williams, 2003; Cohen et al., 2000).

Permissions & Fee and Test Year

The Pain Self-Efficacy Questionnaire was first published in peer-reviewed journal literature in 2007 by Professor Michael K. Nicholas, based upon his earlier clinical developmental work dating back to 1989 at the University of Sydney:

• Copyright Ownership: Copyright © Michael K. Nicholas and the Pain Management Research Institute (University of Sydney / Royal North Shore Hospital).
• Fee Structure and Academic Availability: The PSEQ is widely made accessible free of charge for non-commercial academic research, routine individual clinical practice, and public hospital applications. Clinicians and researchers are permitted to reproduce and administer the scale provided full academic attribution is maintained, the items are not modified, and no commercial fee is charged to respondents.
• Commercial and Clinical Trial Use: Commercial entities, pharmaceutical clinical trials, or commercial software developers integrating the PSEQ into proprietary digital health platforms should contact the author or the University of Sydney's commercialization offices to seek formal licensing permissions.

References

• Adams, J. H., & Williams, A. C. de C. (2003). What affects return to work for patients with chronic pain? Physiotherapy, 89(12), 698–706. https://doi.org/10.1016/S0031-9406(05)60494-0
• Bandura, A. (1977). Self-efficacy: Toward a unifying theory of behavioral change. Psychological Review, 84(2), 191–215. https://doi.org/10.1037/0033-295X.84.2.191
• Bandura, A. (1997). Self-efficacy: The exercise of control. W. H. Freeman and Company.
• Cohen, M. L., Nicholas, M. K., & Blanch, A. (2000). Medical assessment and management of work-related musculoskeletal pain. In M. K. Nicholas & E. J. E. Molloy (Eds.), Pain in the workplace: Management of disability (pp. 57–72). IASP Press.
• Coughlan, G. M., Ridout, K. L., Williams, A. C. de C., & Richardson, P. H. (1995). Predicting maintenance of improvements following cognitive-behavioral treatment of chronic pain. Pain, 61(3), 441–448. https://doi.org/10.1016/0304-3959(94)00207-Y
• Engel, G. L. (1977). The need for a new medical model: A challenge for biomedicine. Science, 196(4286), 129–136. https://doi.org/10.1126/science.847460
• Nicholas, M. K. (2007). The pain self-efficacy questionnaire: Taking pain into account. European Journal of Pain, 11(2), 153–163. https://doi.org/10.1016/j.ejpain.2005.12.008
• Turk, D. C., & Flor, H. (1999). The cognitive-behavioral approach to pain management. In P. D. Wall & R. Melzack (Eds.), Textbook of pain (4th ed., pp. 1325–1338). Churchill Livingstone.
• Vlaeyen, J. W., & Linton, S. J. (2000). Fear-avoidance and its consequences in chronic musculoskeletal pain: A state of the art. Pain, 85(3), 317–332. https://doi.org/10.1016/S0304-3959(99)00242-0
• Vong, S. K. S., Cheing, G. L. Y., Chan, C. C. H., Chan, F., & Leung, A. S. L. (2009). Measurement structure of the Pain Self-Efficacy Questionnaire in a sample of Chinese patients with chronic pain. Clinical Rehabilitation, 23(11), 1034–1043. https://doi.org/10.1177/0269215509337446

Items of the Scale